Abstract
Momordica charantia L. has been remained a well-known medicinal vegetable used traditionally. However, which part is most effective against which disorder, has been remained undiscovered yet. The objective of this study was to examine the antimicrobial, antihyperlipidemic and antihyperglycemic activities of peel, flesh, and seeds of bitter gourd, through in vitro and in vivo assays. Ethanolic extracts from powders of three fractions of bitter gourd were assessed for antimicrobial potential against bacterial and fungal strains, whereas, powders of these fractions were used to determine antihyperlipidemic and antihyperglycemic activity, in alloxan induced diabetic rats. Our results showed that BSE exhibited better antimicrobial activity against Bacillus cereus, whereas BFE exhibited better against Escherichia coli. Blood glucose was significantly lowered by all three powders in a dose dependent manner, when fed to diabetic rats, with the highest decrease by BSP, which reduced the glucose level from 296.20 ± 2.00 mg/dl to 123.10 ± 0.80 mg/dl, at 15 mg dose, after 28 days trial. Elevated levels of TC (101.18 ± 0.65 mg/dl), TG (83.69 ± 0.61 mg/dl) and LDL–C (25.90 ± 0.09 mg/dl) in positive control rats were lowered down in well manners by BSP at 15 mg dose, to 86.30 ± 0.53, 67.70 ± 0.53 and 19.32 ± 0.06 mg/dl, respectively. As compared to BFP and BPP, BSP showed significant involvement in antibacterial, antihyperglycemic, and antihyperlipidemic actions. Along with the edible flesh, peels and seeds, which are usually discarded as waste, could also be utilized for development of pharma foods capable of promoting health.
Similar content being viewed by others
Data Availability
Data relevant to this study can be provided upon request from corresponding author.
References
Mahwish SF, Sultan MT, Riaz A et al (2021) Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment. Plants 10:730. https://doi.org/10.3390/plants10040730
Singh P, Tripathi MK, Yasir M et al (2020) Potential inhibitors for SARS-CoV-2 and functional food components as nutritional supplement for COVID-19: a review. Plant Foods Hum Nutr 75:458–466. https://link.springer.com/article/https://doi.org/10.1007/s11130-020-00861-9
Hussain A, Kausar T, Sehar S et al (2023) A review on biochemical constituents of pumpkin and their role as pharma foods; a key strategy to improve health in post COVID 19 period. Food Prod Proces Nutr 5:22. https://fppn.biomedcentral.com/articles/https://doi.org/10.1186/s43014-023-00138-z
Gayathry KS, John JA et al (2022) A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Prod Proces Nutr 4:10. https://doi.org/10.1186/s43014-022-00089-x
Valyaie A, Azizi M, Kashi A et al (2021) Evaluation of growth, yield, and biochemical attributes of bitter gourd (Momordica charantia L.) cultivars under Karaj conditions in Iran. Plants 10:1370. https://doi.org/10.3390/plants10071370
Semiz A, Sen A (2007) Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. Afr J Biotech 6:273–277. https://www.ajol.info/index.php/ajb/article/view/56180
Tan SP, Stathopoulos C, Parks S et al (2014) An Optimised Aqueous Extract of Phenolic compounds from bitter melon with high antioxidant capacity. Antioxidants 3:814–829. https://doi.org/10.3390/antiox3040814
Kulkarni P, Lohidasan S, Mahadik K et al (2021) Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn. Nat Prod Res 35:1035–1037. https://doi.org/10.1080/14786419.2019.1613400
Lee SH, Jeong YS, Song J et al (2017) Phenolic acid, carotenoid composition, and antioxidant activity of bitter melon (Momordica charantia L.) at different maturation stages. Int J Food Prop 20:S3078–S3087. https://doi.org/10.1080/10942912.2016.1237961
Lucas EA, Dumancas GG, Smith BJ et al (2010) Health benefits of bitter melon (Momordica charantia). Bioactive foods in promoting health. Elsevier, pp 525–549. https://doi.org/10.1016/B978-0-12-374628-3.00035-9
Perera WH, Shivanagoudra SR, Pérez JL et al (2021) Anti-inflammatory, antidiabetic properties and in silico modeling of cucurbitane-type triterpene glycosides from fruits of an Indian cultivar of Momordica charantia L. Molecules 26:1038. https://doi.org/10.3390/molecules26041038
Xu B, Li Z, Zeng T et al (2022) Bioactives of Momordica charantia as potential anti-diabetic/hypoglycemic agents. Molecules 27:2175. https://doi.org/10.3390/molecules27072175
Richter E, Geetha T, Burnett D et al (2023) The effects of Momordica charantia on type 2 diabetes mellitus and Alzheimer’s disease. Int J Mol Sci 24:4643. https://doi.org/10.3390/ijms24054643
Asif M, Naqvi SAR, Sherazi TA et al (2017) Antioxidant, antibacterial and antiproliferative activities of pumpkin (cucurbit) peel and puree extracts - an in vitro study. Pak J Pharma Sci 30:1327–1334. http://www.pjps.pk/uploads/pdfs/30/4/Paper-20.pdf
Hussain A, Kausar T, Din A et al (2021) Antioxidant and antimicrobial properties of pumpkin (Cucurbita maxima) peel, flesh and seeds powders. Biol Agric Healthc 11:42–51. https://doi.org/10.7176/JBAH/11-6-05
Hannan JMA, Rokeya B, Faruque O et al (2003) Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of type 2 diabetic model rats. J Ethnopharmacol 88:73–77. https://doi.org/10.1016/S0378-8741(03)00190-9
Zhu Y, Dong Y, Qian X et al (2012) Effect of superfine grinding on antidiabetic activity of bitter melon powder. Int J Mol Sci 13:14203–14218. https://doi.org/10.3390/ijms131114203
Caili F, Huan S, Quanhong L (2006) A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum Nutr 61: 73–80. https://link.springer.com/article/10.1007/s11130-006-0016-6
Ozusaglam MA, Karakoca K (2016) Antimicrobial and antioxidant activities of Momordica charantia from Turkey. Afric J Biotech 12:1548–1558. https://www.ajol.info/index.php/ajb/article/view/128722
Hussain A, Kausar T, Jamil MA et al (2022) In vitro role of pumpkin parts as pharma-foods: antihyperglycemic and antihyperlipidemic activities of pumpkin peel, flesh, and seed powders, in alloxan-induced diabetic rats. Int J Food Sci 2022:4804408. https://doi.org/10.1155/2022/4804408
Degré R, Sylvestre M (1983) Effect of butylated hydroxyanisole on the cytoplasmic membrane of Staphylococcus aureus Wood 46. J Food Protec 46:206–209. https://doi.org/10.4315/0362-028X-46.3.206
Adams GG, Imran S, Wang S et al (2011) The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines. Food Res Int 44:862–867. https://doi.org/10.1016/j.foodres.2011.03.016
Huang CY, Chen SD (2022) Application of high pressure processing on ultrasonically treated extract from wild bitter gourd. Processes 10:1926. https://doi.org/10.3390/pr10101926
Al-Bukhaiti WQ, Al-Dalali S, Li H et al (2023) Identification and in vitro characterization of novel antidiabetic peptides released enzymatically from peanut protein. Plant Foods Hum Nutr 78:1–7. https://link.springer.com/article/10.1007/s11130-023-01118-x
Białek A, Jelińska M, Białek M et al (2020) The effect of diet supplementation with pomegranate and bitter melon on Lipidomic profile of serum and cancerous tissues of rats with mammary tumours. Antioxid (Basel) 9:243. https://doi.org/10.3390/antiox9030243
Etgeton SAP, Ávila S, Silva ACR et al (2023) Nutritional composition, simulated digestion and biological activities of Campomanesia xanthocarpa fruit. Plant Foods Hum Nutr 78: 1–7. https://link.springer.com/article/10.1007/s11130-023-01126-x
Ference BA, Ginsberg HN, Graham I et al (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38:2459–2472. https://doi.org/10.1093/eurheartj/ehx144
Gazwi HS, Hassan MS, Ismail HA, El-Naem GFA, Tony SK (2023) The hypoglycemic and hypolipidemic effects of polyphenol-rich strawberry juice on diabetic rats. Plant Foods Hum Nutr 78: 512–519. https://link.springer.com/article/10.1007/s11130-023-01079-1
Funding
No funds in any form, from any source were availed for this research work.
Author information
Authors and Affiliations
Contributions
A. H. and S. A. K. Conceptualization; K. K. and A. S. Data curation; M. R. A. Formal analysis; H. F Funding acquisition, Investigation; S. A. Methodology, Project administration; S. A. and S. A. K. Resources; S. K. and A. A. Software; A. H. Supervision; M. Q. A Validation, Visualization; A. H. Roles/Writing – original draft; A. H., S. Y. and S. A. K, Writing – review and editing.
Corresponding author
Ethics declarations
Ethical Approval
This study involved experiments on rats. Therefore, appropriate protocols for protecting the ethical rights of all animals were utilized during the execution of the research. This study was approved by Animal Ethical Committee, College of Biochemistry & Pharmacy, University of Sargodha (SU/AESC/283/Nov/23/2021), for 3 months trials.
Consent for publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hussain, A., Korma, S.A., Kabir, K. et al. In vitro and In vivo Determination of Biological Activities of Bitter Gourd (Momordica charantia L.) Peel, Flesh and Seeds. Plant Foods Hum Nutr (2024). https://doi.org/10.1007/s11130-024-01153-2
Accepted:
Published:
DOI: https://doi.org/10.1007/s11130-024-01153-2